Coreline Soft said on the 19th that it supplied its artificial intelligence (AI) chest diagnosis platform "AVIEW LCS Plus" to a radiology specialty clinic in Germany.
The company supplied AVIEW LCS Plus to Röntgenpraxis Chemnitz, a private radiology center in the same region, following a public medical institution in Chemnitz, Saxony, Germany, on the nth.
The platform is a differentiated all-in-one AI solution that analyzes automatic detection of pulmonary nodules, quantification of emphysema, and coronary artery calcification simultaneously with a single low-dose computed tomography (CT) scan. With one exam, it enables early detection not only of lung cancer but also of chronic obstructive pulmonary disease (COPD) and cardiovascular disease.
Röntgenpraxis is a leading radiology specialty medical institution in Saxony, Germany, that has provided imaging diagnostics for local residents for more than 30 years since its founding in 1990. It has enhanced its capabilities in interpreting large volumes of advanced diagnostic imaging such as CT and magnetic resonance imaging (MRI) annually, as well as in image analysis for patients with lung cancer and chronic lung disease.
Coreline Soft assessed that supplying diagnostic devices to public and private medical institutions in Germany shows that an AI-centered diagnostic ecosystem is becoming a reality, including consistency in patient screening experiences, standardization of diagnostic criteria, and collaboration among hospitals within the region.
The company is carrying out medical infrastructure projects at the national level in major European countries, including Germany, France, and Italy. It recently launched the integrated screening operations platform "AVIEW HUB," providing a solution in which AI goes beyond image analysis to cover workflow management, quality control, and cross-checking of readings. AVIEW recently surpassed a cumulative 2.5 million image readings worldwide.
A Coreline Soft official said, "As Germany and others have released AI essential recommendation guidelines, if this spreads across Europe, AVIEW's market share is expected to expand," and added, "We will strengthen our identity as 'a company that runs national screenings with AI,' moving beyond being an AI company."